HBM BioCapital

• News 30
• 1
• 2023 Ad hoc announcement pursuant to Art
• 53 LR: HBM Healthcare Investments informs about a temporary change in the Executive Board
• News 20
• 1
• 2023 Ad hoc announcement pursuant to Art
• 53 LR: HBM Healthcare Investments publishes Quarterly Report with key figures for the quarter ended 31 December 2022 and for the first nine months of the 2022/2023 financial year
• News 20
• 1
• 2023 Quarterly Report December 2022
• News 24
• 7
• 2022 Zuger Firma finanziert die Medikamente der Zukunft - Interview with Dr Andreas Wicki

Healthcare – an attractive investment universe

The healthcare sector is worldwide among the most important and fast growing industries Key growth drivers are demographic trends (population growth and ageing), medical progress and the resulting innovations, rising prosperity (especially in emerging markets) and improved access to medical products and services In addition, there is a great need for new therapies for a steadily increasing number of diseases Innovation in products, services and business models remains strong

Global portfolio of private and public companies

Over the past years, HBM Healthcare Investments’ net asset value (NAV) per share and share price (HBMN) have demonstrated an attractive performance Over the same period, the average dividend yield was between 3 and 5 percent per year